Article
N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Genes & development - 1 Aug 2004
Kuo Mei-Ling, den Besten Willem, Bertwistle David, Roussel Martine F, Sherr Charles J
Abstract excerpt
Unknown mechanisms govern degradation of the p19Arf tumor suppressor, an activator of p53 and inhibitor of ribosomal RNA processing. Kinetic metabolic labeling of cells with [3H]-leucine indicated that p19Arf is a relatively stable protein (half-life approximately 6 h) whose degradation depends upon the ubiquitin-proteasome pathway. Although p19Arf binds to the Mdm2 E3 ubiquitin protein ligase to activate p53,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
